Ghatak S - Search Results

1

Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer.

Misra S, Ghatak S, Vyas A, O'Brien P, Markwald RR, Khetmalas M, Hascall VC, McCarthy JB, Karamanos NK, Tammi MI, Tammi RH, Prestwitch GD, Padhye S. Misra S, et al. Among authors: ghatak s. Med Chem Res. 2014 Aug 1;23(8):3836-3851. doi: 10.1007/s00044-014-0958-4. Med Chem Res. 2014. PMID: 25013352 Free PMC article.

2

Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway.

Ghatak S, Misra S, Toole BP. Ghatak S, et al. J Biol Chem. 2002 Oct 11;277(41):38013-20. doi: 10.1074/jbc.M202404200. Epub 2002 Jul 26. J Biol Chem. 2002. PMID: 12145277 Free article.

3

Regulation of multidrug resistance in cancer cells by hyaluronan.

Misra S, Ghatak S, Zoltan-Jones A, Toole BP. Misra S, et al. Among authors: ghatak s. J Biol Chem. 2003 Jul 11;278(28):25285-8. doi: 10.1074/jbc.C300173200. Epub 2003 May 8. J Biol Chem. 2003. PMID: 12738783 Free article.

4

Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells.

Ghatak S, Misra S, Toole BP. Ghatak S, et al. J Biol Chem. 2005 Mar 11;280(10):8875-83. doi: 10.1074/jbc.M410882200. Epub 2005 Jan 4. J Biol Chem. 2005. PMID: 15632176 Free article.

5

Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2.

Misra S, Ghatak S, Toole BP. Misra S, et al. Among authors: ghatak s. J Biol Chem. 2005 May 27;280(21):20310-5. doi: 10.1074/jbc.M500737200. Epub 2005 Mar 22. J Biol Chem. 2005. PMID: 15784621 Free article.

6

Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions.

Toole BP, Zoltan-Jones A, Misra S, Ghatak S. Toole BP, et al. Among authors: ghatak s. Cells Tissues Organs. 2005;179(1-2):66-72. doi: 10.1159/000084510. Cells Tissues Organs. 2005. PMID: 15942194 Review.

7

Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells.

Misra S, Toole BP, Ghatak S. Misra S, et al. Among authors: ghatak s. J Biol Chem. 2006 Nov 17;281(46):34936-41. doi: 10.1074/jbc.C600138200. Epub 2006 Sep 7. J Biol Chem. 2006. PMID: 16959784 Free article.

8

Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells.

Misra S, Obeid LM, Hannun YA, Minamisawa S, Berger FG, Markwald RR, Toole BP, Ghatak S. Misra S, et al. Among authors: ghatak s. J Biol Chem. 2008 May 23;283(21):14335-44. doi: 10.1074/jbc.M703811200. Epub 2008 Mar 7. J Biol Chem. 2008. PMID: 18326857 Free PMC article.

9

Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer.

Misra S, Hascall VC, Berger FG, Markwald RR, Ghatak S. Misra S, et al. Among authors: ghatak s. Connect Tissue Res. 2008;49(3):219-24. doi: 10.1080/03008200802143356. Connect Tissue Res. 2008. PMID: 18661347 Review.

10

Hyaluronan oligosaccharides as a potential anticancer therapeutic.

Toole BP, Ghatak S, Misra S. Toole BP, et al. Among authors: ghatak s. Curr Pharm Biotechnol. 2008 Aug;9(4):249-52. doi: 10.2174/138920108785161569. Curr Pharm Biotechnol. 2008. PMID: 18691085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters